This policy report, produced in collaboration with PATH, reviews some of the cost and financing requirements for HPV vaccine adoption in developing countries. In particular, it examines the cervical cancer burden, characteristics of HPV vaccines, delivery challenges, likely cost and cost effectiveness of HPV vaccination, and funding needs and solutions in developing country settings.